A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists

MedChemComm
2015.0

Abstract

Several recent studies have focused on a detailed analysis of the trace amine-associated receptor type 5 (TAAR5) pharmacology, up to now revealing only a limited number of species-specific ligands, which are also active towards other TAAR receptors. In this context, we developed our work on TAAR5 applying a structure-based computational protocol, revolving around homology modeling and virtual screening calculations. In detail, mTAAR5 and hTAAR5 homology models were built, in order to explore any pattern of structural requirements which could be involved in species-specific differences. Successively, the mTAAR5 model was employed to perform a virtual screening of an in-house library of compounds, including different five-membered ring derivatives, linked to a phenyl ring through a flexible or a rigid basic moiety. The computational protocol applied allowed to select a number of chemical scaffolds that were tested in a biological assay leading to the discovery of the first two mTAAR5 antagonists.

Knowledge Graph

Similar Paper

A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists
MedChemComm 2015.0
Discovery of trace amine-associated receptor 1 ligands by molecular docking screening against a homology model
MedChemComm 2015.0
Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies
European Journal of Medicinal Chemistry 2017.0
Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study
Journal of Medicinal Chemistry 2016.0
Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists
Journal of Medicinal Chemistry 2015.0
Rational design, chemical synthesis and biological evaluation of novel biguanides exploring species-specificity responsiveness of TAAR1 agonists
European Journal of Medicinal Chemistry 2018.0
Identification of a novel NR2B-selective NMDA receptor antagonist using a virtual screening approach
Bioorganic & Medicinal Chemistry Letters 2010.0
Discovery of KDM5A inhibitors: Homology modeling, virtual screening and structure–activity relationship analysis
Bioorganic & Medicinal Chemistry Letters 2016.0
Computer-Aided Design and Synthesis of 5-Substituted Tryptamines and Their Pharmacology at the 5-HT1D Receptor: Discovery of Compounds with Potential Anti-Migraine Properties
Journal of Medicinal Chemistry 1995.0
Optimisation of imidazole compounds as selective TAAR1 agonists: Discovery of RO5073012
Bioorganic & Medicinal Chemistry Letters 2012.0